iVIZIA TAKES HOME 2023 APEX AWARD

iVIZIA® Honored in the Ophthalmology Category

The Pharmaceutical Executive® APEX Awards celebrate excellence in pharmaceutical advertising, branding, and disease education. This one-of-a-kind award show is unique in that it is judged exclusively by the very individuals who benefit from the campaigns themselves—healthcare professionals and patients. The Elevate client campaign for iVIZIA® was honored as the winner in the Ophthalmology (Branded) category at this year’s event.

iVIZIA won the award for “Covering the Spectrum of Dry Eye Relief”—their healthcare professional campaign. The campaign impressed the judges enough to earn the award. The campaign showcases the iVIZIA brand and its formulation, depicted by different colors in the spectrum, each representing a unique benefit of the product. The campaign’s success is further validated by the multiple readership score awards it has won from industry publications.

Elevate also had another client campaign nominated as finalist at this year’s APEX Awards. The Oncology category featured Elevate work for Medexus Pharma and their campaign for the optical imaging agent Gleolan®, “See More. Resect More.” The campaign creates awareness and evokes disdain toward cancer. The headline emphasizes the power of Gleolan in allowing neurosurgeons to see and resect malignant tissue, leaving residual tumors with nowhere to hide.

All of us here at Elevate are extremely proud of our team members and client partners who helped bring these campaigns to life.

See all of the APEX Award winners here.

Pharmaceutical Executive® is a leading publication providing pharmaceutical and biopharmaceutical executives with in-depth analysis of business, strategy, and government regulations. With a commitment to delivering industry insights beyond the headlines, Pharmaceutical Executive® conducts interviews and roundtable discussions with thought leaders and business experts to help executives navigate the complex challenges faced by the pharmaceutical industry.